EUVIMEDEUVIMED entdecken
Crossref

Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy

Weili Zhang, Yuxin Gu, Xiajuan Xue, Xudan Li, Weifeng Wang, Ruowei Wang, Jiahua He, Weihao Li, Yue Xing, Yuguang Lin, Jianhong Peng

Clinical and Translational Oncology · 2025

DOI: 10.1007/s12094-025-04029-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Weili Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Cen…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Ploidies, Antineoplastic Combined Chemotherapy Protocols, Stromal Cells. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Science and Technology Planning Project of Shenzen Municipality, Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: DNA ploidy (P), stroma fraction (S), and nucleotyping (N), collectively known as PSN, have demonstrated prognostic accuracy in various stages of colorectal cancer (CRC). However, the prognostic value of the PSN panel in stage IIIb colon cancer patients receiving CapOX adjuvant chemotherapy remains unclear. PATIENTS AND METHODS: Postoperative pathological samples from stage IIIb colon cancer patients who underwent radical surgery and postoperative adjuvant chemotherapy at Sun Yat-sen University Cancer Center were retrospectively collected. Kaplan-Meier and Cox regression were performed to compare survival among subgroups of patients stratified by PSN, in order to elucidate the benefits of different durations of adjuvant CapOX chemotherapy. RESULT: The PSN low-risk group had the highest 5-year DFS (95.77% vs. 83.07% vs. 84.29%, P = 0.023). Multivariate Cox regression analysis identified primary tumor location (HR = 4.166, 95% CI 1.616-10.742, P = 0.003), perineural invasion (HR = 2.358, 95% CI 1.205-4.615, P = 0.012), and PSN high risk (HR = 3.830, 95% CI 1.352-10.853, P = 0.011) as independent predictors of DFS. No significant difference in 5-year DFS and overall survival (OS) was observed between patients receiving 4-7 cycles and those receiving 8 cycles of CapOX (DFS: 86.24% vs. 88.77%, P = 0.082; OS: 96.38% vs. 94.23%, P = 0.088). However, in the PSN high-risk group, completing 8 cycles of CapOX significantly improved 5-year DFS and OS compared to 4-7 cycles (DFS: 93.10% vs. 77.04%, P = 0.033; OS: 96.30% vs. 91.24%, P = 0.037). In contrast, no significant difference in DFS was observed in the IDEA (International Duration Evaluation of Adjuvant therapy)-based high-risk group (DFS: 85.85% vs. 80.75%, P = 0.062; OS: 97.56% vs. 87.05%, P = 0.598). CONCLUSION: The PSN panel effectively stratifies stage IIIb colon cancer, aiding in optimized adjuvant chemotherapy duration determination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsPloidiesAntineoplastic Combined Chemotherapy ProtocolsStromal CellsDNA, NeoplasmHumansFemaleChemotherapy, AdjuvantMaleMiddle AgedPrognosisRetrospective StudiesAgedNeoplasm StagingAdultOxaliplatinCyclophosphamideSurvival Rate

Stichwörter der Autor:innen

Colon cancerDNA ploidyNucleotypingPrognosisStroma fraction

Substanzen

OxaliplatinCyclophosphamideDNA, Neoplasm

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, 510060, People's Republ…
  • Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, People's Republic of China.
  • Department of Colorectal Surgery, Zhangzhou Municipal Hospital Affiliated of Fujian Medical University, Zhangzhou, Fujian, 363000, People's Republic of China.
  • Oncology Department of Kangmei Hospital, Puning, Guangdong, 515300, People's Republic of China.
  • Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510060, People's Republic of China. xingy28@mail.sysu.edu.cn.
  • Department of Gastroenterology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, 518036, People's Republic of China. 31550662@qq.com.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Science and Technology Planning Project of Shenzen Municipality
  • Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Zhang, W., Gu, Y., Xue, X., Li, X., Wang, W., Wang, R., He, J., Li, W., Xing, Y., Lin, Y., & Peng, J. (2025). Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04029-2

Vancouver

Zhang W, Gu Y, Xue X, Li X, Wang W, Wang R, et al. Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04029-2

BibTeX
@article{Zhang2025,
  author = {Zhang, Weili and Gu, Yuxin and Xue, Xiajuan and Li, Xudan and Wang, Weifeng and Wang, Ruowei and He, Jiahua and Li, Weihao and Xing, Yue and Lin, Yuguang and Peng, Jianhong},
  title = {Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy},
  journal = {Clinical and Translational Oncology},
  year = {2025},
  doi = {10.1007/s12094-025-04029-2}
}
Kostenlos starten →